A Community and Hospital cAre Bundle to improve the medical treatment of cLaudIcation and critical limb iSchaemia. The CHABLIS study

niversity of Leicester0 个研究点目标入组 120 人开始时间: 2021年1月27日最近更新: 2024年4月22日

适应症

试验速览

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/37881303/ (added 29/11/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36690397/ embedded qualitative feasibility results (added 29/11/2023) Preprint results see attached file ISRCTN13202085 preprint results.pdf (added 09/04/2024) 2024 Results article in https://doi.org/10.1186/s40814-024-01445-z, (added 09/04/2024)

•1. Adult (>18 years of age) patient with incapacitating intermittent claudication or chronic limb threatening ischaemia (Rutherford stages 3–6)
•2. Referred to secondary care, either in a clinic or for inpatient treatment
•3. Willing and able to give written informed consent for participation in the study
•4. Access to a telephone or computer with internet access (for those taking part in remote interviews/consensus meeting)
•Healthcare professionals:
•5. Healthcare professionals who provide care to patients with have symptomatic peripheral arterial disease

•1. Female participants who are pregnant, lactating or planning a pregnancy during the course of the study
•2. Patients who do not have the capacity to consent for themselves
•3. Patients with a life-limiting condition whereby conservative management is most appropriate
•4. Patients with asymptomatic peripheral arterial disease

发起方

niversity of Leicester